Skip to main content
. 2021 Jan 11;5(1):262–273. doi: 10.1182/bloodadvances.2020002185

Table 1.

Patient’s characteristics before allo-HSCT

No. (%) of cases with available information Overall LAD type I LAD type III P
N (%) 84 (100) 69 (82) 11 (13)
Sex, n (%) 83 (99) .858
 Female 40 (48) 32 (46) 6 (55)
 Male 43 (52) 37 (54) 5 (45)
Age at diagnosis, mo 84 (100) .214
 Median 3 3 7
 IQR 1-12 1-10 3-17
 Range 0-131 0-131 0-50
Time between diagnosis and allo-HSCT, mo 84 (100)
 Median 7 8 7 .442
 IQR 3-17 3-20 2-13
 Range 1-353 1-353 1-46
Infections before allo-HSCT, n (%) 51 (61) .224
 Yes 45 (88) 37 (93) 7 (78)
 No 6 (12) 3 (7) 2 (22)
Recurrence of infections before allo-HSCT, n (%) 32 (71)* .120
 Once with 1 infection 1 (3) 0 1 (33)
 Once with 2 or more simultaneous infections 21 (66) 19 (68) 2 (67)
 Twice with 2 or more simultaneous infections 8 (25) 7 (25) 0
 More than twice with more simultaneous infections 2 (6) 2 (7) 0

IQR, interquartile range.

*

This percentage corresponds to n = 45 patients with infections.